BIOHM is a series a startup based in United States. 1 investor tracked.
BIOHM is a company founded in 2017 headquartered in the United States. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
BIOHM is a microbiome company that develops supplements and testing kits designed to address the total microbiome of both bacteria and fungi in the gut.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.